• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Stories

Making Medical History

Home > Stories

Making Medical History

Dr Bernard Pécoul, Sharon Stone, and Dr Anthony S. Fauci
1 Nov 2018

DNDi‘s 15th Anniversary Gala Dinner – 24 October 2018 – NYC

It’s not every day that you have the chance to eliminate one of the world’s most neglected diseases.

It’s also not every day that a group of global health leaders and celebrities in a downtown New York hotel gives a standing ovation to a researcher from the Democratic Republic of Congo (DRC), thousands of miles from the equatorial rain forests where this disease kills. And it’s certainly not every day that the presenter is none other than the “son of Congo,” NBA Hall of Famer and President of the Dikembe Mutombo Foundation, presenting an award designed and donated by one of DRC’s leading sculptors.

But this perfectly sums up last Wednesday evening: the honoree was Dr Victor Kande, the principal Congolese researcher behind the first all-oral treatment for sleeping sickness; the presenter was Dikembe Mutombo; and the award was designed by Professor Alfred Liyolo.

Dr Kande was being honored for Making Medical History – the title of our night. The treatment he helped develop could finally put the elimination of sleeping sickness in our sights, potentially becoming the second disease to ever be eliminated.

A standing ovation for a Congolese doctor

On Wednesday, 24 October, the Drugs for Neglected Diseases initiative (DNDi) organized the Making Medical History Gala at the Bowery Hotel in New York City in celebration of DNDi’s 15-year anniversary. More than 180 friends, supporters, partners, celebrities, and global health influencers attended the Cocktail and Awards Dinner, and another 150-200 joined for a fantastic After Party featuring world-renowned musicians DJ Logic, Falu Shah, Mino Cinélu, Foday Musa Suso, and Constant Boty.

The evening was emceed by doctor and journalist Dr Javid Abdelmonein, and the other presenters and honorees included Sharon Stone, presenting the Visionary Award to Dr Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases at the U.S. National Institutes of Health; Alek Wek, the South Sudanese supermodel, presenting the Founder’s Award to Doctors Without Borders/Médecins Sans Frontières (accepted on behalf of MSF by Dr Joanne Liu, International President); and DNDi’s own Dr Wilfried Mutombo, presenting the Excellence in Journalism Award to HuffPost (accepted by Jo Confino and Paul Josephson).

Dr Javid Abdelmonein

The evening, DNDi’s first-ever Gala, raised almost $500,000 for DNDi’s lifesaving work.

Take a few seconds to browse some images from that memorable night! 

Sharon Stone and Alek Wek
Dikembe Mutombo
https://twitter.com/DNDi/status/1055258073751785473?s=20
The Founder’s Award to Doctors Without Borders/Médecins Sans Frontières was accepted on behalf of MSF by Dr Joanne Liu, International President
Sanofi was the presenting sponsor, and many other partners sponsored the event. Pictured here: Luc Kuykens – Senior Vice President Global Health Programs at Sanofi and Leslie Roessle
The Visionary Award to Dr Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases at the U.S. National Institutes of Health, was presented by American actress Sharon Stone

Photo credits: Alison Wright & Daniela Kirsch

Funding Sleeping sickness

Read, watch, share

Loading...
Stories
16 Jul 2026

Annie Liang: How students’ advocacy helped bring mycetoma out of the shadows

Publications
16 Jul 2026

DNDi 2025 Annual Report

Laboratory of Medicinal and Computational Chemistry (LQMC), São Paulo University USP, São Carlos Campus, São Paulo Brazil.
Press releases
13 Jul 2026

DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security 

Chepokarial Rubben attentively cares for her five-year-old son, Romanu Kiptoo, at the kala-azar ward of Kacheliba Sub-County Referral Hospital in West Pokot County, Kenya. She gently soothes him, offering comfort as he endures the painful treatment for kala-azar.
Press releases
13 Jul 2026

DNDi welcomes GHIT support to advance novel oral drug candidate for leishmaniasis, accelerating progress towards elimination goals

Press releases
8 Jul 2026

Brazil, Malaysia, and Thailand set to start global clinical trial to test promising dengue treatment developed by Serum Institute of India

Patricia, 44, from Area 44 in Lilongwe, Malawi, has lived with vision loss for 10 years following a late diagnosis of cryptococcal meningitis.
Stories
30 Jun 2026

Cryptococcal meningitis: Africa’s neglected HIV killer

News
29 Jun 2026

Eric Easom, Dr Marcus Lacerda, and Mathieu Lamiaux join the DNDi Board of Directors 

Publications
29 Jun 2026

Advancing global health innovation through Europe-Africa collaboration

VIEW ALL

Help neglected patients

To date, we have delivered fourteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Youtube X-twitter Tiktok Facebook-f
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license